These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9066615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Significance of long-term follow-up in xeroderma pigmentosum.
    Min JA, Lee JY, Cho BK, Park HJ.
    Int J Dermatol; 2010 Jun; 49(6):720-2. PubMed ID: 20618485
    [No Abstract] [Full Text] [Related]

  • 23. Xeroderma pigmentosa with basal cell carcinoma and coexistent multicentric neurofibroma on face.
    Mandal S, Jain S, Mandal AK.
    Pathology; 2010 Apr; 42(3):290-1. PubMed ID: 20350226
    [No Abstract] [Full Text] [Related]

  • 24. [Xeroderma pigmentosum: report of 6 cases in Dakar].
    Dieng MT, Niang SO, Dangou JM, Ndiaye B.
    Bull Cancer; 2001 Feb; 88(2):199-202. PubMed ID: 11257594
    [Abstract] [Full Text] [Related]

  • 25. Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream.
    Nagore E, Sevila A, Sanmartin O, Botella-Estrada R, Requena C, Serra-Guillen C, Sanchez-Pedreño P, Guillen C.
    Br J Dermatol; 2003 Oct; 149(4):858-61. PubMed ID: 14616381
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Xeroderma pigmentosum.
    Norgauer J, Idzko M, Panther E, Hellstern O, Herouy Y.
    Eur J Dermatol; 2003 Oct; 13(1):4-9. PubMed ID: 12609773
    [Abstract] [Full Text] [Related]

  • 30. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.
    Hauschild A, Eichstaedt J, Möbus L, Kähler K, Weichenthal M, Schwarz T, Weidinger S.
    Eur J Cancer; 2017 May; 77():84-87. PubMed ID: 28365530
    [No Abstract] [Full Text] [Related]

  • 31. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A.
    Cancer Res; 1998 Oct 01; 58(19):4402-9. PubMed ID: 9766670
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Keratoacanthomas and xeroderma pigmentosum (author's transl)].
    Tennstedt D, Lachapelle JM.
    Ann Dermatol Venereol; 1977 Feb 01; 104(2):98-102. PubMed ID: 869458
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Ocular malignancies of xeroderma pigmentosum: clinical and therapeutic features].
    Touzri RA, Mohamed Z, Khalil E, Ilhem MB, Insaf M, Bassima F, Amel MO.
    Ann Dermatol Venereol; 2008 Feb 01; 135(2):99-104. PubMed ID: 18342089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.